Skip to main content
Clinical Trials/NCT00629577
NCT00629577
Terminated
Phase 1

Ex Vivo Gene Expression Profiling of Cervical Cancer Progression in Biopsies And Tissue Samples From Patients With Cervical Lesions

British Columbia Cancer Agency1 site in 1 country50 target enrollmentSeptember 2006

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Cervical Cancer
Sponsor
British Columbia Cancer Agency
Enrollment
50
Locations
1
Primary Endpoint
Classification of cervical cancer progression at a molecular level using gene expression profiling
Status
Terminated
Last Updated
9 years ago

Overview

Brief Summary

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research trial is studying gene expression profiling of cervical cancer progression in biopsies and tissue samples from patients with cervical lesions.

Detailed Description

OBJECTIVES: * Classify cervical cancer progression at a molecular level using gene expression profiling generated from expression microarrays. * Profile gene expression changes of dysplasia and early carcinoma of uterine cervical tissue at a molecular level using expression microarrays. * Define a set of genes that classify the various grades of cervical cancer/dysplasia at a molecular level. * Compare the expression profiles of clinical data to determine how accurately cell lines model the in vivo environment. OUTLINE: Patients undergo colposcopy and a cervical smear is taken for flow cytometry analysis. Patients also undergo 2 biopsies from one clinically abnormal or normal site. Tissue samples are analyzed by gene expression profiling using human expression microarrays containing approximately 40,000 unique sequences. Data analysis consists of defining a set of genes, containing new targets for biomarkers, that classify the biopsies into 3 grades.

Registry
clinicaltrials.gov
Start Date
September 2006
End Date
December 2011
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Classification of cervical cancer progression at a molecular level using gene expression profiling

Gene expression changes by microarray

Comparison of the expression profiles of clinical data to determine how accurately cell lines model the in vivo environment

Set of genes that classify the various grades of cervical cancer/dysplasia

Study Sites (1)

Loading locations...

Similar Trials